Sale
  • Immunohistochemistry - Anti  hnRNP A2B1 Antibody [DP3B3] on lung tissue sections showing squamous cell carcinoma
  • Immunohistochemistry - Anti hnRNP A2B1 Antibody [DP3B3] on lung tissue sections showing squamous cell carcinoma
  • HeLa lysate run on 4-12% Bis-Tris 2D gel in 1 x MOPS running buffer. Transfer to 0.45µm nitrocellulose. Membrane probed with DP3B3 (anti-hnRNP). Anti-mouse IgG (whole molecule)-AP conjugate (1 in 2,000). Detection with BCIP/NBT substrate.

Current Image Legend:




hnRNP A2B1 Monoclonal Antibody [DP3B3]

Catalogue Number: IQ215

Catalogue Number: IQ271

Item in Stock Secure Online Payments

If you have any questions or require further information, please contact us and one of our scientists will be in touch.

A free sample may be available. Please click here to request this.

  • £328.90

Datasheet

Download Variant Datasheet
Primary Description: Mouse Anti-hnRNP A2B1 [DP3B3]
Primary Description: hnRNP A2B1 Antibody [DP3B3]
Target Antigen: hnRNP A2B1
Target Antigen: hnRNP A2B1
Catalogue Number: IQ215
Catalogue Number: IQ271
Quantity: 0.1mg
Quantity: 0.05mg
Concentration: 1mg/ml
Concentration: 1mg/ml
Clone: DP3B3
Clone: DP3B3
Host: Mouse
Host: Mouse
Isotype: IgG2a
Isotype: IgG2a
Myeloma/Fusion Partners: SP2/0
Myeloma/Fusion Partners: SP2/0
Immunogen: Full length bacterially expressed His-hnRNP-A2 fusion protein (Human)
Immunogen: Full length bacterially expressed His-hnRNPA2 fusion protein (Human) 
Species Reactivity: Chicken, Human, Mouse, Rat, Pig
Species Reactivity: Chicken, Human, Mouse, Rat, Pig
Purification: Protein A
Purification: Protein A
Format: Purified antibody (from supernatant) containing PBS 0.1% sodium azide;
Format: Purified antibody (from supernatant) containing PBS 0.1% sodium azide;
Applications: ICC/IF, IHC-Fr, IHC-P, WB
Applications: ICC/IF, IHC-Fr, IHC-P, WB
Dilutions: Optimal antibody dilution should be determined by titration, however as a guideline try;IHC-Fr: 1/100. PubMed: 17067748Fix with acetoneWB: 1/1500 - 1/6000. Detects a band of approximately 37 kDa (predicted molecular weight: 37 kDa)IHC-P:Use a concentration of 1µg/ml.
Dilutions: Optimal antibody dilution should be determined by titration, however as a guideline try; IHC-Fr: 1/100. PubMed: 17067748Fix with acetoneWB: 1/1500 - 1/6000. Detects a band of approximately 37 kDa (predicted molecular weight: 37 kDa)IHC-P: Use a concentration of 1µg/m.
Also Known As: Heterogeneous nuclear ribonucleoprotein A2 antibody;Heterogeneous nuclear ribonucleoprotein A2/B1antibody;Heterogeneous nuclear ribonucleoprotein B1 antibody;Heterogeneous nuclear ribonucleoproteins A2/B1antibody;hnRNP A2 antibody;hnRNP A2 / hnRNP B1 antibody;hnRNP B1 antibody;hnRNP-A2 antibody;hnRNP-B1antibody;hnRNPA2 antibody;hnRNPB1 antibody;HNRPA2 antibody;HNRPA2B1 antibody;HNRPB1 antibody;Nuclearribonucleoprotein particle A2 protein antibody;RNP A2 antibody;RNP B1 antibody;RNP-A2 antibody;RNP-B1antibody;RNPA2 antibody;RNPB1 antibody;SNRPB1 antibody
Also Known As: Heterogeneous nuclear ribonucleoprotein A2 antibody;Heterogeneous nuclear ribonucleoprotein A2/B1antibody;Heterogeneous nuclear ribonucleoprotein B1 antibody;Heterogeneous nuclear ribonucleoproteins A2/B1antibody;hnRNP A2 antibody;hnRNP A2 / hnRNP B1 antibody;hnRNP B1 antibody;hnRNP-A2 antibody;hnRNP-B1antibody;hnRNPA2 antibody;hnRNPB1 antibody;HNRPA2 antibody;HNRPA2B1 antibody;HNRPB1 antibody;Nuclearribonucleoprotein particle A2 protein antibody;RNP A2 antibody;RNP B1 antibody;RNP-A2 antibody;RNP-B1antibody;RNPA2 antibody;RNPB1 antibody;SNRPB1 antibody
Pubmed ID(s): 31201338, 29191962, 29533781, 29293066, 30034552, 30044993, 28137911, 28943950, 28981879, 28247913, 29070672, 28297716, 26657151, 26830971, 27375925, 27111068, 26622731, 26635566, 24462217, 23861442, 23935508, 22322011, 22205302, 21321021, 21632565, 20133837, 20351270, 21099359, 18245461, 18371932, 16294306, 17067748, 15671034, 15838865Previous, 17095106, 21903368, 18801469, 18544163, 17477362, 17483488, 16980303, 16246864, 15838865, 29191962, 29533781, 30034552, 28981879, 28297716, 2121021
Pubmed ID(s): 31201338, 29191962, 29533781, 29293066, 30034552, 30044993, 28137911, 28943950, 28981879, 28247913, 29070672, 28297716, 26657151, 26830971, 27375925, 27111068, 26622731, 26635566, 24462217, 23861442, 23935508, 22322011, 22205302, 21321021, 21632565, 20133837, 20351270, 21099359, 18245461, 18371932, 16294306, 17067748, 15671034, 15838865Previous
Entrez Gene ID(s): 3181, 117282
Entrez Gene ID(s): 3181, 117282
SwissProt ID(s): O88569, P22626
SwissProt ID(s): O88569, P22626
Omim ID(s): 600124
Omim ID(s): 600124

Citations

Citation Count: 43
Citations:

Kwon J et al. Functional roles of hnRNPA2/B1 regulated by METTL3 in mammalian embryonic development. Sci Rep 9:8640 (2019).
View Source


Hock EM et al. Hypertonic Stress Causes Cytoplasmic Translocation of Neuronal, but Not Astrocytic, FUS due to Impaired Transportin Function. Cell Rep 24:987-1000.e7 (2018).
View Source


Kuljittichanok D et al. Effect of Derris scandens extract on a human hepatocellular carcinoma cell line. Oncol Lett 16:1943-1952 (2018).
View Source


Val S et al. Nontypeable Haemophilus influenzae lysates increase heterogeneous nuclear ribonucleoprotein secretion and exosome release in human middle-ear epithelial cells. FASEB J 32:1855-1867 (2018).
View Source


Morita M et al. PKM1 Confers Metabolic Advantages and Promotes Cell-Autonomous Tumor Cell Growth. Cancer Cell 33:355-367.e7 (2018).
View Source


Zhou N et al. Cellular proteomic analysis of porcine circovirus type 2 and classical swine fever virus coinfection in porcine kidney-15 cells using isobaric tags for relative and absolute quantitation-coupled LC-MS/MS. Electrophoresis 38:1276-1291 (2017).
View Source


Xiang Y et al. RNA m6A methylation regulates the ultraviolet-induced DNA damage response. Nature 543:573-576 (2017).
View Source


Cai Y et al. Broad Susceptibility of Nucleolar Proteins and Autoantigens to Complement C1 Protease Degradation. J Immunol 199:3981-3990 (2017).
View Source


Singh NN et al. Activation of a cryptic 5' splice site reverses the impact of pathogenic splice site mutations in the spinal muscular atrophy gene. Nucleic Acids Res 45:12214-12240 (2017).
View Source


Subhasitanont P et al. Apigenin inhibits growth and induces apoptosis in human cholangiocarcinoma cells. Oncol Lett 14:4361-4371 (2017).
View Source


Paul KR et al. Effects of Mutations on the Aggregation Propensity of the Human Prion-Like Protein hnRNPA2B1. Mol Cell Biol 37:N/A (2017). WB ; Drosophila melanogaster .
View Source


Seo J et al. Oxidative Stress Triggers Body-Wide Skipping of Multiple Exons of the Spinal Muscular Atrophy Gene. PLoS One 11:e0154390 (2016). WB .
View Source


Douglas JN et al. Antibodies to the RNA Binding Protein Heterogeneous Nuclear Ribonucleoprotein A1 Colocalize to Stress Granules Resulting in Altered RNA and Protein Levels in a Model of Neurodegeneration in Multiple Sclerosis. J Clin Cell Immunol 7:402 (2016).
View Source


Ottesen EW et al. Severe impairment of male reproductive organ development in a low SMN expressing mouse model of spinal muscular atrophy. Sci Rep 6:20193 (2016). WB .
View Source


Ceccon M et al. Excess of NPM-ALK oncogenic signaling promotes cellular apoptosis and drug dependency. Oncogene 35:3854-3865 (2016).
View Source


Meparishvili M et al. A Proteomic Study of Memory After Imprinting in the Domestic Chick. Front Behav Neurosci 9:319 (2015). WB .
View Source


Qu XH et al. Insights into the roles of hnRNP A2/B1 and AXL in non-small cell lung cancer. Oncol Lett 10:1677-1685 (2015).
View Source


Cortese A et al. Widespread RNA metabolism impairment in sporadic inclusion body myositis TDP43-proteinopathy. Neurobiol Aging 35:1491-8 (2014). IHC-Fr ; Human .
View Source


O'Bryan MK et al. RBM5 is a male germ cell splicing factor and is required for spermatid differentiation and male fertility. PLoS Genet 9:e1003628 (2013). WB, IF, IHC ; Mouse .
View Source


Singh NN et al. An intronic structure enabled by a long-distance interaction serves as a novel target for splicing correction in spinal muscular atrophy. Nucleic Acids Res 41:8144-65 (2013). WB .
View Source


Rambaruth ND  et al. The lectin Helix pomatia agglutinin recognizes O-GlcNAc containing glycoproteins in human breast cancer. Glycobiology 22:839-48 (2012). WB, ICC/IF ; Human
View Source


Rambaruth ND et al. The lectin Helix pomatia agglutinin recognizes O-GlcNAc containing glycoproteins in human breast cancer. Glycobiology 22:839-48 (2012). WB, ICC/IF ; Human .
View Source


Cho SB et al. Identification of HnRNP-A2/B1 as a target antigen of anti-endothelial cell IgA antibody in Behçet's disease. J Invest Dermatol 132:601-8 (2012).
View Source


Maeto CA  et al. Differential effect of acute and persistent Junin virus infections on the nucleo-cytoplasmic trafficking and expression of heterogeneous nuclear ribonucleoproteins type A and B. J Gen Virol 92:2181-90 (2011)
View Source


Wong PF et al. Eurycomanone suppresses expression of lung cancer cell tumor markers, prohibitin, annexin 1 and endoplasmic reticulum protein 28. Phytomedicine. 2012 Jan 15;19(2):138-44. doi: 10.1016/j.phymed.2011.07.001. Epub 2011 Sep 7.  WB ; Human
View Source


Liang XH & Crooke ST Depletion of key protein components of the RISC pathway impairs pre-ribosomal RNA processing. Nucleic Acids Res : (2011).
View Source


Maeto CA et al. Differential effect of acute and persistent Junin virus infections on the nucleo-cytoplasmic trafficking and expression of heterogeneous nuclear ribonucleoproteins type A and B. J Gen Virol 92:2181-90 (2011).
View Source


Santarosa M  et al. BRCA1 modulates the expression of hnRNPA2B1 and KHSRP. Cell Cycle 9:4666-4673 (2010). WB ; Human
View Source


Rosenberger S  et al. Alternative splicing of human papillomavirus type-16 E6/E6* early mRNA is coupled to EGF signaling via Erk1/2 activation. Proc Natl Acad Sci U S A : (2010). WB ; Human
View Source


Clower CV  et al. The alternative splicing repressors hnRNP A1/A2 and PTB influence pyruvate kinase isoform expression and cell metabolism. Proc Natl Acad Sci U S A 107:1894-9 (2010). WB ; Human
View Source


Clower CV et al. The alternative splicing repressors hnRNP A1/A2 and PTB influence pyruvate kinase isoform expression and cell metabolism. Proc Natl Acad Sci U S A 107:1894-9 (2010). WB ; Human .
View Source


Rosenberger S et al. Alternative splicing of human papillomavirus type-16 E6/E6* early mRNA is coupled to EGF signaling via Erk1/2 activation. Proc Natl Acad Sci U S A : (2010). WB ; Human .
View Source


Santarosa M et al. BRCA1 modulates the expression of hnRNPA2B1 and KHSRP. Cell Cycle 9:4666-4673 (2010). WB ; Human .
View Source


Honoré B et al. Identification of differentially expressed proteins in spontaneous thymic lymphomas from knockout mice with deletion of p53. Proteome Sci. 2008 Jun 10;6:18. doi: 10.1186/1477-5956-6-18.  WB ; Mouse
View Source


Lee JH  et al. Alterations in Gemin5 expression contribute to alternative mRNA splicing patterns and tumor cell motility. Cancer Res 68:639-44 (2008). WB ; Human
View Source


Nicholls CD et al. Multiple factors influence the normal and UV-inducible alternative splicing of PIG3. Biochim Biophys Acta. 2008 Dec;1779(12):838-49. doi: 10.1016/j.bbagrm.2008.08.009. Epub 2008 Aug 29.  WB ; Human
View Source


Lee JH et al. Alterations in Gemin5 expression contribute to alternative mRNA splicing patterns and tumor cell motility. Cancer Res 68:639-44 (2008). WB ; Human .
View Source


Hua Y et al. Antisense masking of an hnRNP A1/A2 intronic splicing silencer corrects SMN2 splicing in transgenic mice. Am J Hum Genet 82:834-48 (2008).
View Source


Katherine A. Peebles et al. Altered expression of splicing factor, heterogeneous nuclear ribonucleoprotein A2/B1, in mouse lung neoplasia. Molecular Carcinogenesis,3 May 2007  IHC WB ; Mouse
View Source


Zech VF  et al. Prognostic and diagnostic relevance of hnRNP A2/B1, hnRNP B1 and S100 A2 in non-small cell lung cancer. Cancer Detect Prev 30:395-402 (2006). IHC-Fr ; Human
View Source


Strom A  et al. Identification of prion protein binding proteins by combined use of far-Western immunoblotting, two dimensional gel electrophoresis and mass spectrometry. Proteomics 6:26-34 (2006)
View Source


Griffith BN et al. Identification of hnRNPs K, L and A2/B1 as candidate proteins involved in the nutritional regulation of mRNA splicing. Biochim Biophys Acta. 2006 Nov-Dec;1759(11-12):552-61. Epub 2006 Oct 6.  WB ; Mouse
View Source


Strom A et al. Identification of prion protein binding proteins by combined use of far-Western immunoblotting, two dimensional gel electrophoresis and mass spectrometry. Proteomics 6:26-34 (2006).
View Source


Zech VF et al. Prognostic and diagnostic relevance of hnRNP A2/B1, hnRNP B1 and S100 A2 in non-small cell lung cancer. Cancer Detect Prev 30:395-402 (2006). IHC-Fr ; Human .
View Source


Hong OK  et al. Proteomic analysis of differential protein expression in response to epidermal growth factor in neonatal porcine pancreatic cell monolayers. J Cell Biochem 95:769-81 (2005)
View Source


Xia H Regulation of gamma-fibrinogen chain expression by heterogeneous nuclear ribonucleoprotein A1. J Biol Chem 280:13171-8 (2005)
View Source


Iwahashi CK et al. Protein composition of the intranuclear inclusions of FXTAS. Brain. 2006 Jan;129(Pt 1):256-71. Epub 2005 Oct 24.  WB ICC/IF ; Human
View Source


Xia H Regulation of gamma-fibrinogen chain expression by heterogeneous nuclear ribonucleoprotein A1. J Biol Chem 280:13171-8 (2005).
View Source


Hong OK et al. Proteomic analysis of differential protein expression in response to epidermal growth factor in neonatal porcine pancreatic cell monolayers. J Cell Biochem 95:769-81 (2005).
View Source


Molecular characterization of the hnRNP A2/B1 proteins: tissuespecific expression and novel isoforms. Kamma H ( Exp Cell Res.,Feb 1999)
View Source


Protocols

Immunofluorescence protocol - Formaldehyde fixation
  1. Collect cells from T.c.unit and remove media from petri dish using suction.
  2. Wash with 1x PBS and remove.
  3. Incubate cells in pre-warm (37°C) Para-Formaldehyde for 12 minutes at room temperature on an orbital shaker.
  4. Remove PFA and incubate in 0.5% Triton X-IOO in 1x PBS for 5 minutes at room temperature.
  5. Prepare blocking reagent, this is also the antibody diluent.
  6. Wash cells 2x with 1x PBS at room temperature, for 4 minutes/wash on an orbital shaker.
  7. Block with 1 % NCS and 1x PBS for 30 minutes at room temperature.
  8. Prepare primary antibodies (50?l/coverslip) and moist staining chambers.
  9. Wash cells 2x with lx PBS at room temperature and air dry briefly.
  10. Incubate with primary antibody for 1 hr at room temperature in the dark in staining chambers. During this time prepare the secondary antibody.
  11. Wash cells 5x with 1x PBS (5 beaker changes/5 counts in each beaker)
  12. Incubate with secondary antibody for 1 hour at room temperature in the dark in staining chambers.
  13. Wash cells 5x with 1x PBS.
  14. Mount in Dapi.

Solutions (prepare fresh the same day of staining).

  • * 1x Phosphate buffered saline.
  • * Blocking reagent: 1% NCS in 1x PBS (use fresh l0x PBS).
  • * Fixation solution: 3.5% Para formaldehyde.

1.75g PFA in 20 ml d.H20 plus 5 drops 1M NaOH. Stir on a hot plate at 50-60°C until dissolved. Add 4 drops IN HCI and check pH indicator strip. PH should be 7.4. Complete volume with d.H20 to 25ml and add 25ml 2xPBS. Check pH before adding to cover slips.

Immunofluorescence protocol - Methanol/acetone fixation
  1. Collect cells from T.C.unit and remove media from petri dish using suction.
  2. Wash with 1x PBS and remove.
  3. Fix cells with cold methanol: acetone 1: 1 for 10 minutes on ice.
  4. Prepare blocking reagent, this is also the diluent for the antibodies.
  5. Remove fixative and wash cells 3x with Ix PBS at RT, for 4 minutes/wash on orbital shaker.
  6. Block with 1% NCS and Ix PBS for 30 minutes at RT.
  7. Prepare primary antibodies (50?l/coverslip) and moist staining chambers.
  8. Wash cells 2x with 1 x PBS at RT and air dry for approximately 7 minutes.
  9. Incubate with primary antibody for 1 hr at RT in the dark in staining chambers. During this time prepare secondary antibody.
  10. Wash cells 5x with 1x PBS (5 beaker changes/5 counts in each beaker)
  11. Incubate with secondary antibody for 1 hr at R T in the dark in staining chambers.
  12. Wash cells 5x with 1x PBS.
  13. Mount in Dapi.

Solutions (prepare fresh the same day of staining)

  • * 1x Phosphate buffered saline.
  • * Blocking reagent: 1% NCS in 1x PBS (use fresh 10x PBS).
  • * Fixation solution: methanol:acetone 1: 1 ice cold.
Western Blotting Protocol
  1. Transfer gel to PDVF or nitrocellulose membrane
  2. Place membrane in plastic tray in blocking buffer for one hour with agitation
  3. Rinse in wash buffer
  4. Incubate in wash buffer plus primary antibody for one hour
  5. Wash 6 X 5 minutes with wash buffer
  6. Incubate in wash buffer plus secondary antibody for one hour
  7. Wash 6X 5 minutes with wash buffer
  8. Detect (e.g. ECL, Amersham according to manufacturers instructions)
Wash buffer

PBS + 0.1% Tween 20

Blocking buffer

Wash buffer + 5% dried milk powder

The concentration of antibodies used depends on each antibody, the amount of antigen and the detection method used. Generally, dilution is in the range of a few hundred times dilution to a few thousand times dilution, but usually has to be determined empirically.

FAQ's

How do I place an order?

When placing an order we require a purchase order number, plus name and contact details of the purchaser, and the person who will be using the product. We will add VAT for every order received from an EU country, unless you are VAT exempt. For such VAT exempt customers we will need to receive a copy of the exemption certificate with the order.

Orders can be placed either by our website, via email or by mail. Please see our contact us page for more details

All orders are subject to availability. Prices of products do not include shipping, VAT or import duties, where these are applicable. Price and other information provided are subject to change without notice. While every effort is made to keep information provided Up to date, ImmuQuest will not be liable if errors should occur in such information.

Formal acceptance of an order will take place when the goods are dispatched. If prices should be changed between the time of receipt of an order and dispatch, ImmuQuest will contact you in advance.

Ordering via the website

To order via the website you will need to find the product(s) you are looking for by either using our search, browsing our categories or using our full antibody catalogue.

Once you have found the antibodies you are looking for you can view more detailed information about a specific antibody by clicking the product or the 'View' button. Once you are sure it is the antibody you are looking for you can add it to your order by clicking the 'Add To Order' button.

This places the antibody in your order basket, you can add as many antibodies as you wish. Once you have selected all of the antibodies you wish to order then click the checkout button. If you are not logged in you will be asked to login or to register, if you are logged in you will be taken to the checkout page.

On the checkout page you are able to double check your order and enter a purchase order number if you have one.

Once you are happy your order is correct you can purchase the order with debit/credit card details and your order will be submitted. Once we have received and checked your order we will contact you to arrange payment and delivery.

How long does delivery take?

Delivery usually takes no more than one week from reciept of an order.

Do you guarantee your antibodies?

Yes. Should any product not perform as described in the product literature, it will be replaced or a full refund will be given. The customer must notify ImmuQuest within 30 days after the goods have been received to request a replacement, forwarding complete test data as requested by ImmuQuest.

If items are ordered incorrectly by the customer, ImmuQuest will consider taking them back as long as they have been stored correctly and have not been opened or tampered with. Such orders may be subject to a 15% restocking charge on the items plus any shipping costs.

Requests for returns must have prior authorization from ImmuQuest, and must be made within 7 days of receipt of the items. Items must be returned in the same or equivalent packaging as originally dispatched, and by an equivalent method of delivery.

Do you charge VAT?

If you are in the EU and you are no exempt from paying VAT then we must charge VAT (charged at the prevailing UK rate).

Customers that are exempt need to fax an exemption form showing their vat exemption number.

What if I don't have a purchase order number?

You can still place an order without providing a purchase order number but we must recieve payment before your order is despatched.

Non-website orders

Non-website orders can be placed directly with Immuquest at sales@immuquest.com or click on the "contact us" tab for address details

Delivery

Offline Orders

For offline orders please call +44 (0) 1642 713533 or click here to email us.

Delivery & returns

We use federal Express for UK & international shipments, andfor standard shipments the cost is £30 UK & £55 international. If the customer uses their account, we charge a £20 handling fee (UK & international)

We are strongly committed to providing the best quality products, and the best service possible.

Should any product not perform as described in the product literature, it will be replaced or a full refund will be given. The customer must notify ImmuQuest within 30 days after the goods have been received to request a replacement, forwarding complete test data as requested by ImmuQuest.

If items are ordered incorrectly by the customer, ImmuQuest will consider taking them back as long as they have been stored correctly and have not been opened or tampered with. Such orders may be subject to a 15% restocking charge on the items plus any shipping costs.

Requests for returns must have prior authorization from ImmuQuest, and must be made within 7 days of receipt of the items. Items must be returned in the same or equivalent packaging as originally dispatched, and by an equivalent method of delivery.

Product Guarantee

We are strongly committed to providing the best quality products, and the best service possible. In order to do this we depend on your feedback.

Should any product not perform as described in the product literature, it will be replaced or a full refund will be given. The customer must notify ImmuQuest within 30 days after the goods have been received to request a replacement, forwarding complete test data as requested by ImmuQuest.

If items are ordered incorrectly by the customer, ImmuQuest will consider taking them back as long as they have been stored correctly and have not been opened or tampered with. Such orders may be subject to a 15% restocking charge on the items plus any shipping costs.

Requests for returns must have prior authorization from ImmuQuest, and must be made within 7 days of receipt of the items. Items must be returned in the same or equivalent packaging as originally dispatched, and by an equivalent method of delivery.

If you have any questions please contact us using the following details:

ImmuQuest Ltd
Springboard
Stokesley Business Park
24 Ellerbeck Way
Stokesley
TS9 5JZ
UK

Tel: 01642 713533
Fax: 01642 713988
International Tel: +44 1642 713533
International Fax: +44 1642 713988

When placing an order ImmuQuest require a purchase order number, plus name and contact details of the purchaser, and the person who will be using the product. ImmuQuest will also need a VAT number for customers in the European Union.UK customers that are VAT exempt need to fax an exemption certificate.

Orders can be placed either by our website, via email or by mail. Please see our contact us page for more details. All orders are subject to availability. Prices of products do not include shipping, VAT or import duties where these are applicable.

Price and other information provided are subject to change without notice. While every effort is made to keep information provided Up to date, ImmuQuest will not be liable if errors should occur in such information. Formal acceptance of an order will take place when the goods are dispatched. If prices should be changed between the time of receipt of an order and dispatch, ImmuQuest will contact you in advance.